1.	UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 18 to 80 Sponsor: NCI, Other Protocol IDs: CDR0000396464, P30CA046592, CCUM-2004-0535, CCUM-2062, N01-CN-25025-3, NCT00098969
2.	Resveratrol for Patients With Colon Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: UCI 05-20, 2005-4333, NCT00256334
3.	Phase I Study of Resveratrol in Patients With Resectable Colorectal Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: CCUM-TASK2B, LRI-6930, N01-CN-25025-4, NCT00433576
4.	Phase I Biomarker Study of Dietary Grape-Derived Low Dose Resveratrol for Colon Cancer Prevention Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: OCRT07046, Foundation grant, NCT00578396
5.	Resveratrol in Healthy Adult Participants Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000600296, P30CA023074, UARIZ-BIO-07-0376-04, BIO #07-0376-04, UAZ06-8-01, NCT00721877
6.	Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 13 and over Sponsor: Other Protocol IDs: 2010-0276, NCT01201694
7.	Phase I Pilot Study of Resveratrol in Postmenopausal Women With High Body Mass Index Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 35 and over Sponsor: NCI Protocol IDs: UARIZ-UAZ08-12-01, 10-0653-04, UAZ08-12-01, NCT01370889
8.	Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: CO 10308, R21CA149560, NCT01324089